Long-Term Safety and Effectiveness of a Continuous Erythropoietin Receptor Activator (CERA) in Patients With Renal Anemia: A Prospective, Observational, Multicenter Study
Renal Replacement Therapy
doi 10.1186/s41100-019-0221-z
Full Text
Open PDFAbstract
Available in full text
Date
June 6, 2019
Authors
Publisher
Springer Science and Business Media LLC